EARNINGS PER SHARE (Tables)

3 Months Ended

Mar. 31, 2019

Schedule of Earnings Per Share, Basic and Diluted

The components of basic and diluted earnings per share are as follows:



	For the Three Months Ended March 31,
	2019			2018
Income from continuing operations	$	11,751		$	6,756
Net loss attributable to noncontrolling interests	7			178
Less: preferred share accretion paid in kind (Note 13)	—			(2,447		)
Less: income allocated to Series B Preferred Shares	(3,482		)	(1,838		)
Income from continuing operations available to common shareholders, net of noncontrolling interest	8,276			2,649
Income from discontinued operations, net of tax	—			316
Less income allocated to Series B Preferred Shares	—			(129		)
Net income attributable to CME Ltd. available to common shareholders — basic	8,276			2,836

Effect of dilutive securities
Dilutive effect of employee stock options, RSUs and Series B Preferred Shares	9			469
Net income attributable to CME Ltd. available to common shareholders — diluted	$	8,285		$	3,305

Weighted average outstanding shares of common stock — basic ⁽¹⁾	264,199			158,039
Dilutive effect of employee stock options, RSUs and common stock warrants	1,012			83,866
Weighted average outstanding shares of common stock — diluted	265,211			241,905

Net income per share:
Continuing operations — basic	$	0.03		$	0.02
Continuing operations — diluted	0.03			0.01
Discontinued operations — basic	—			0.00
Discontinued operations — diluted	—			0.00
Attributable to CME Ltd. — basic	0.03			0.02
Attributable to CME Ltd. — diluted	$	0.03		$	0.01


⁽¹⁾	For the purpose of computing basic earnings per share, the 11,211,449 shares of Class A common stock underlying the Series A Preferred Share are included in the weighted average outstanding shares of common stock - basic, because the rights of the Series A Preferred Share are considered substantially similar to that of our Class A common stock.

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

eighted-average equity awards and convertible shares are excluded from the calculation of diluted earnings per share if their effect would be anti-dilutive. The following instruments were anti-dilutive but may be dilutive in future periods:



	For the Three Months Ended March 31,
	2019	2018
RSUs	1,064	903
Total	1,064	903